Experts' guidelines for the management of dyslipidemias differ from country to country, with important differences between medical societies of Europe and the United States. Recently, new American and European guidelines have been established. These guidelines mainly differ for cardiovascular risk stratification in secondary prevention, and for LDL-cholesterol (LDL-c) goals to achieve. Similitudes between guidelines include the global strategy to initiate lipid-lowering drugs, which is based first on the global cardiovascular risk, then on the LDL-c level. We are here presenting a comparison and an interpretation of these guidelines
peer reviewedCardiovascular diseases are the leading cause of mortality in the so-called industrial ...
peer reviewedA patient with abdominal obesity, type 2 diabetes, arterial hypertension and dyslipidae...
Several studies published in 2020 showed new data supporting the prescription of statins in some old...
Experts' guidelines for the management of dyslipidemias differ from country to country, with importa...
peer reviewedThe pharmacological treatment of dyslipidaemia, essentially by statins, should take pla...
peer reviewedAbout a decade ago the Belgian Hypertension Committee endorsed the guidelines for the m...
RésuméLes maladies cardiovasculaires restent la cause principale de mortalité. Quatre facteurs de ri...
peer reviewedL’hypertension artérielle reste un des facteurs de risque cardiovasculaire les plus fré...
peer reviewedLes statines, en complément des mesures hygiéno-diététiques, occupent une place de prem...
editorial reviewedPCSK9 (Proprotein Convertase Subtilisin/Kexin type 9) inhibition has proven its in...
SummaryBackgroundScreening for and management of dyslipidaemia are crucial in primary and secondary ...
Familial dyslipidemia is rare compared to polygenetic causes. Nevertheless, it is important not to m...
peer reviewedThe concept of "polypill" for cardiovascular prevention was introduced in 2003 in a lan...
peer reviewedGuidelines for the management of arterial hypertension are regularly updated. This arti...
International audienceRecently, ANSES gave a prudent advice concerning consumption of plant sterols/...
peer reviewedCardiovascular diseases are the leading cause of mortality in the so-called industrial ...
peer reviewedA patient with abdominal obesity, type 2 diabetes, arterial hypertension and dyslipidae...
Several studies published in 2020 showed new data supporting the prescription of statins in some old...
Experts' guidelines for the management of dyslipidemias differ from country to country, with importa...
peer reviewedThe pharmacological treatment of dyslipidaemia, essentially by statins, should take pla...
peer reviewedAbout a decade ago the Belgian Hypertension Committee endorsed the guidelines for the m...
RésuméLes maladies cardiovasculaires restent la cause principale de mortalité. Quatre facteurs de ri...
peer reviewedL’hypertension artérielle reste un des facteurs de risque cardiovasculaire les plus fré...
peer reviewedLes statines, en complément des mesures hygiéno-diététiques, occupent une place de prem...
editorial reviewedPCSK9 (Proprotein Convertase Subtilisin/Kexin type 9) inhibition has proven its in...
SummaryBackgroundScreening for and management of dyslipidaemia are crucial in primary and secondary ...
Familial dyslipidemia is rare compared to polygenetic causes. Nevertheless, it is important not to m...
peer reviewedThe concept of "polypill" for cardiovascular prevention was introduced in 2003 in a lan...
peer reviewedGuidelines for the management of arterial hypertension are regularly updated. This arti...
International audienceRecently, ANSES gave a prudent advice concerning consumption of plant sterols/...
peer reviewedCardiovascular diseases are the leading cause of mortality in the so-called industrial ...
peer reviewedA patient with abdominal obesity, type 2 diabetes, arterial hypertension and dyslipidae...
Several studies published in 2020 showed new data supporting the prescription of statins in some old...